Novystemnanoclusters have shown an exceptional efficacy in preclinical models and thus represent an ideal therapeutic solution to treat FRDA.
Oxidative stress plays a central role in disease pathogenesis.
The condition is characterized by:
Novystemnanoclusters have shown an exceptional efficacy in preclinical models and thus represent an ideal therapeutic solution to treat FRDA.
Oxidative stress plays a central role in disease pathogenesis.
The condition is characterized by:
Progressive ataxia of the limbs
Dysarthria and dysphagia
Oculomotor dysfunction
Scoliosis
Cardyomiopathy
Diabetes
Loss of vision and of hearing
Novystem nanoclusters have shown an exceptional efficacy in preclinical models and thus represent an ideal therapeutic solution to treat FRDA